Angiotensin II Antagonist in Severe Sepsis

NCT01992796 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Severe Sepsis

Interventions

DRUG: Irbesartan

Sponsor

University of Salerno

Collaborators

[object Object]